ORM 1 as a Biomarker of Increased Vascular Invasion and Decreased Sorafenib Sensitivity in Hepatocellular Carcinoma

By
lbeveridge
-
0
51
Researchers clarified the role of Orosomucoid 1 (ORM1) in the development and therapy resistance in HCC.
[BJBMS]
Abstract